Orthocell Limited (OCC.AX)
- Previous Close
0.3800 - Open
0.3850 - Bid 0.3750 x 3162600
- Ask 0.3850 x 365000
- Day's Range
0.3750 - 0.3850 - 52 Week Range
0.3200 - 0.4600 - Volume
33,180 - Avg. Volume
125,286 - Market Cap (intraday)
78.498M - Beta (5Y Monthly) 0.10
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0400 - Earnings Date Feb 23, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Orthocell Limited, a regenerative medicine company, develops and commercializes cell therapies and biological medical devices for the repair of various bone and soft tissue injuries in Australia. The company offers CelGro, a naturally derived collagen medical device for use in multiple indications to augment the surgical repair of bone, peripheral nerves, tendons, and cartilage; and Ortho-ATI, a cell therapy for treatment of chronic tendon injuries. It also provides Ortho-ACI, an autologous chondrocyte implantation to treat articular cartilage defects in the knee and ankle; Striate+, a resorbable collagen membrane used for guided bone and tissue regeneration in dental procedure; and Remplir, a collagen scaffold used in peripheral nerve repair. Orthocell Limited was incorporated in 2006 and is headquartered in Murdoch, Australia.
orthocell.comRecent News: OCC.AX
Performance Overview: OCC.AX
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: OCC.AX
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: OCC.AX
Valuation Measures
Market Cap
78.50M
Enterprise Value
59.63M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
15.48
Price/Book (mrq)
36.04
Enterprise Value/Revenue
12.42
Enterprise Value/EBITDA
-4.93
Financial Highlights
Profitability and Income Statement
Profit Margin
-154.57%
Return on Assets (ttm)
-26.69%
Return on Equity (ttm)
-177.01%
Revenue (ttm)
4.8M
Net Income Avi to Common (ttm)
-7.42M
Diluted EPS (ttm)
-0.0400
Balance Sheet and Cash Flow
Total Cash (mrq)
19.62M
Total Debt/Equity (mrq)
34.88%
Levered Free Cash Flow (ttm)
-5.02M
Company Insights: OCC.AX
OCC.AX does not have Company Insights